Growing community of inventors

Osaka, Japan

Keisuke Narukawa

Average Co-Inventor Count = 11.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Keisuke NarukawaAtsushi Yamashita (1 patent)Keisuke NarukawaSatoshi Obika (1 patent)Keisuke NarukawaTsuyoshi Yamamoto (1 patent)Keisuke NarukawaTakeshi Imanishi (1 patent)Keisuke NarukawaTetsuji Yamaoka (1 patent)Keisuke NarukawaMariko Shiba (1 patent)Keisuke NarukawaSachiro Kakinoki (1 patent)Keisuke NarukawaHidetaka Torigoe (1 patent)Keisuke NarukawaYoichi Tachibana (1 patent)Keisuke NarukawaKiyomi Sasaki (1 patent)Keisuke NarukawaTachibana Yoichi (0 patent)Keisuke NarukawaKeisuke Narukawa (1 patent)Atsushi YamashitaAtsushi Yamashita (45 patents)Satoshi ObikaSatoshi Obika (30 patents)Tsuyoshi YamamotoTsuyoshi Yamamoto (20 patents)Takeshi ImanishiTakeshi Imanishi (18 patents)Tetsuji YamaokaTetsuji Yamaoka (6 patents)Mariko ShibaMariko Shiba (3 patents)Sachiro KakinokiSachiro Kakinoki (3 patents)Hidetaka TorigoeHidetaka Torigoe (1 patent)Yoichi TachibanaYoichi Tachibana (1 patent)Kiyomi SasakiKiyomi Sasaki (1 patent)Tachibana YoichiTachibana Yoichi (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Osaka University (1 from 987 patents)

2. National Cerebral and Cardiovascular Center (1 from 49 patents)

3. Tokyo University of Science Education Foundation Administrative Organization (1 from 2 patents)

4. Tokyo University of Science Educational Foundation Administrative Organization (34 patents)


1 patent:

1. 9127280 - Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…